Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis Theme



Etiam ultricies nisi vel augue. Curabitur ullamcorper ultricies

The No.1 Research Site For Therapeutic Peptides


Thymosin Alpha 1 10mg


Thymosin Alpha 1 10mg

Thymosin Alpha 1 (Tα1) is a peptide originally isolated from the thymus gland, an organ responsible for the maturation of immune cells known as T-cells. Tα1 is a 28-amino acid peptide with a wide range of immunomodulatory effects. It has been shown to enhance the immune system’s response to infections and cancers while also exhibiting anti-inflammatory and anti-viral properties.

Previous and ongoing research on Thymosin Alpha 1 has focused on several key areas:

  1. Immunomodulation: Tα1 has been shown to stimulate the production and maturation of immune cells such as T-cells, natural killer (NK) cells, and dendritic cells. This enhancement of the immune response has been studied in the context of various infections, autoimmune diseases, and cancer.
  2. Anti-viral activity: Tα1 has demonstrated anti-viral properties against various viruses, including hepatitis B and C, human immunodeficiency virus (HIV), and herpes simplex virus (HSV). It has been investigated as a potential therapy for patients with chronic viral infections.
  3. Cancer therapy: Due to its ability to modulate the immune system and directly induce tumor cell apoptosis, Tα1 has been studied for its potential role in cancer therapy. Research has focused on its use as an adjuvant therapy to improve the effectiveness of existing cancer treatments.
  4. Autoimmune diseases: Tα1’s immunomodulatory effects have also been explored in the context of autoimmune diseases, where it may help to restore immune system balance and reduce inflammation.

Current research on Thymosin Alpha 1 is focused on further understanding its mechanisms of action, optimizing its therapeutic applications, and investigating its safety and efficacy in various populations and medical conditions. Some recent research papers related to Thymosin Alpha 1 include:

  1. Romani, L., et al. (2021). “Thymosin α1: The long journey of a thymic peptide with immunotherapeutic potential.” International Immunopharmacology, 99, 107991. [This review paper provides an overview of the history, mechanisms of action, and therapeutic applications of Thymosin Alpha 1.]
  2. Li, M., et al. (2021). “Thymosin alpha 1 as an adjuvant treatment for viral pneumonia: A systematic review and meta-analysis of randomized controlled trials.” International Immunopharmacology, 91, 107292. [This meta-analysis investigates the potential benefits of Thymosin Alpha 1 as an adjuvant treatment for viral pneumonia.]
  3. Wu, J., et al. (2020). “Thymosin Alpha 1: Biological activities, applications, and genetic engineering production.” Peptides, 125, 170228. [This review paper summarizes the biological activities, potential applications, and methods for producing Thymosin Alpha 1.]
  4. Niu, X., et al. (2020). “Thymosin α1 therapy in critically ill patients with COVID-19: A multicenter retrospective cohort study.” International Immunopharmacology, 88, 106873. [This study investigates the effects of Thymosin Alpha 1 therapy in critically ill patients with COVID-19.]

Peptides are the future of medicine. They are potent, tissue specific and effective at treating a variety of conditions with little to no side effects.

Dean Henry
Function Medicine Coach and Health Optimiser

Peptides are the next frontier in biohacking and performance enhancement. They can boost muscle growth, accelerate fat loss, improve sleep, increase energy and focus, and promote overall health and longevity.

Ben Greenfield
Biohacker and Health Expert

Peptides are tiny chains of amino acids that have powerful effects on the brain and body. They can improve memory, focus, and mood, and have anti-anxiety and anti-depressant effects.

Dr. Andrew Huberman, PhD
Professor of Neurobiology at Stanford University